Przemysława Jarosz-Chobot Selected Research

Przemysława Jarosz-Chobot Research Topics

Disease

27	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2004
7	Hyperglycemia 04/2022 - 05/2008
5	Type 2 Diabetes Mellitus (MODY) 01/2018 - 09/2008
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2010
4	Diabetes Mellitus 01/2016 - 01/2009
3	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 05/2008
3	Insulin Resistance 01/2013 - 09/2008
2	Infections 01/2021 - 01/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2017 - 01/2010
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2007 - 01/2005
1	Disease Progression 01/2022
1	Body Weight (Weight, Body) 11/2021
1	Diabetes Complications 01/2021
1	IgA Deficiency 01/2021
1	Overweight 01/2021
1	Atrophy 01/2020
1	Weight Gain 10/2018
1	Striae Distensae 01/2017
1	Graves Disease (Basedow Disease) 01/2017
1	Myasthenia Gravis 01/2017
1	Pain (Aches) 02/2016
1	Critical Illness (Critically Ill) 01/2016
1	Ketosis 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Familial Partial Lipodystrophy (Dunnigan Syndrome) 01/2013
1	Autism Spectrum Disorder 01/2011
1	Disease Susceptibility (Diathesis) 01/2010
1	Hemorrhage 01/2010
1	Atherosclerosis 01/2006
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2006
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2006

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 11/2021 - 01/2004
7	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 05/2008
4	AntibodiesIBA 01/2019 - 01/2010
4	Blood Glucose (Blood Sugar)IBA 02/2016 - 05/2008
3	GlucokinaseIBA 04/2022 - 01/2017
3	LipidsIBA 01/2021 - 01/2005
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 01/2005
2	ApolipoproteinsIBA 01/2021 - 01/2006
2	AutoantibodiesIBA 01/2017 - 01/2010
2	Metformin (Glucophage)FDA LinkGeneric 01/2009 - 09/2008
2	AndrogensIBA 09/2008 - 01/2006
1	Rituximab (Mabthera)FDA Link 01/2022
1	Trace Elements (Biometals)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ProteomeIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Immunoglobulin D (IgD)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Immunoglobulin IsotypesIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	ProinsulinIBA 01/2020
1	N 30IBA 01/2020
1	C-PeptideIBA 01/2019
1	3-aminopropyltrimethoxysilaneIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Inosine Triphosphate (ITP)IBA 01/2017
1	Platelet Membrane GlycoproteinsIBA 01/2017
1	Aligeron (AS 2)IBA 01/2016
1	AntigensIBA 01/2016
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2013
1	Lamin Type A (Lamin A)IBA 01/2013
1	SteroidsIBA 01/2010
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 05/2008
1	Apolipoproteins B (ApoB)IBA 01/2006
1	HDL CholesterolIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Lipoproteins (Lipoprotein)IBA 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2004

Therapy/Procedure

13	Therapeutics 01/2022 - 09/2008
4	Glycemic Control 11/2021 - 05/2008
1	Mediterranean Diet 01/2019
1	Artificial Pancreas 01/2019
1	Immunotherapy 12/2016
1	Catheters 01/2007